Detalles de la búsqueda
1.
Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers.
Br J Cancer
; 113(7): 1010-9, 2015 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26372697
2.
HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer.
Cancers (Basel)
; 13(4)2021 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33562755
Resultados
1 -
2
de 2
1
Próxima >
>>